Anthony Croft

1.0k total citations
17 papers, 324 citations indexed

About

Anthony Croft is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Anthony Croft has authored 17 papers receiving a total of 324 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Genetics, 11 papers in Epidemiology and 6 papers in Surgery. Recurrent topics in Anthony Croft's work include Inflammatory Bowel Disease (15 papers), Microscopic Colitis (9 papers) and IL-33, ST2, and ILC Pathways (4 papers). Anthony Croft is often cited by papers focused on Inflammatory Bowel Disease (15 papers), Microscopic Colitis (9 papers) and IL-33, ST2, and ILC Pathways (4 papers). Anthony Croft collaborates with scholars based in Australia, New Zealand and Canada. Anthony Croft's co-authors include Graham Radford‐Smith, James D. Doecke, Richard B. Gearry, Alissa Walsh, Jane M. Andrews, R Cooley, Peter A. Bampton, Ian C. Lawrance, Timothy H. Florin and Anton Lord and has published in prestigious journals such as Gastroenterology, Alimentary Pharmacology & Therapeutics and Clinical Nutrition.

In The Last Decade

Anthony Croft

15 papers receiving 319 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anthony Croft Australia 9 245 203 81 77 49 17 324
Timothy E. Ritter United States 11 279 1.1× 215 1.1× 89 1.1× 110 1.4× 50 1.0× 38 442
Evanthia Zampeli Greece 9 181 0.7× 140 0.7× 127 1.6× 122 1.6× 22 0.4× 26 379
Shashi Adsul United States 10 243 1.0× 170 0.8× 54 0.7× 120 1.6× 43 0.9× 35 318
Ivan Ferkolj Slovenia 11 276 1.1× 193 1.0× 111 1.4× 120 1.6× 39 0.8× 23 416
Mireia Peñalva Spain 6 217 0.9× 170 0.8× 50 0.6× 121 1.6× 24 0.5× 16 300
Katrien Asnong Belgium 4 343 1.4× 294 1.4× 61 0.8× 112 1.5× 24 0.5× 5 389
Janelle Laskowski United States 5 312 1.3× 212 1.0× 136 1.7× 81 1.1× 12 0.2× 7 381
B G Feagan Canada 7 369 1.5× 262 1.3× 200 2.5× 90 1.2× 24 0.5× 28 512
Jill Fennell United Kingdom 4 455 1.9× 360 1.8× 139 1.7× 192 2.5× 41 0.8× 5 534
Daniel Quirk United States 11 315 1.3× 229 1.1× 57 0.7× 109 1.4× 19 0.4× 20 390

Countries citing papers authored by Anthony Croft

Since Specialization
Citations

This map shows the geographic impact of Anthony Croft's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anthony Croft with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anthony Croft more than expected).

Fields of papers citing papers by Anthony Croft

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anthony Croft. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anthony Croft. The network helps show where Anthony Croft may publish in the future.

Co-authorship network of co-authors of Anthony Croft

This figure shows the co-authorship network connecting the top 25 collaborators of Anthony Croft. A scholar is included among the top collaborators of Anthony Croft based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anthony Croft. Anthony Croft is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Croft, Anthony, et al.. (2025). Sequential rescue therapy with JAK inhibitors in corticosteroid and infliximab-refractory acute severe ulcerative colitis: a case series. Therapeutic Advances in Gastroenterology. 18. 1128506487–1128506487.
2.
Croft, Anthony, et al.. (2024). Tumor-Induced Osteomalacia in a Patient with Crohn’s Disease: A Case Report and Approach to Investigating Hypophosphatemia. Case Reports in Gastroenterology. 18(1). 81–89.
3.
Bryant, Robert G., Susan J. Connor, Anthony Croft, et al.. (2024). P854 Tofacitinib demonstrates preliminary efficacy in induction of remission in chronic pouchitis. Journal of Crohn s and Colitis. 18(Supplement_1). i1573–i1573. 3 indexed citations
4.
Croft, Anthony, Satomi Okano, Günter Härtel, et al.. (2024). A personalised algorithm predicting the risk of intravenous corticosteroid failure in acute ulcerative colitis. Alimentary Pharmacology & Therapeutics. 60(7). 921–933. 1 indexed citations
5.
Croft, Anthony, et al.. (2022). Viral Enteric Infections in Acute Severe Ulcerative Colitis. Journal of Crohn s and Colitis. 16(8). 1335–1339. 2 indexed citations
6.
Croft, Anthony, Anton Lord, & Graham Radford‐Smith. (2022). Markers of Systemic Inflammation in Acute Attacks of Ulcerative Colitis: What Level of C-reactive Protein Constitutes Severe Colitis?. Journal of Crohn s and Colitis. 16(7). 1089–1096. 28 indexed citations
7.
Marsh, Abigail, et al.. (2021). Outcomes of dietary management approaches in active ulcerative colitis: A systematic review. Clinical Nutrition. 41(2). 298–306. 9 indexed citations
8.
Irwin, James, Nicole Walker, Aisling McMahon, et al.. (2014). Hospitalization and treatment costs for acute, severe, steroid-refractory ulcerative colitis: Infliximab beats ciclosporin. Journal of Gastroenterology and Hepatology. 29. 123–123. 3 indexed citations
9.
Doecke, James D., Lisa A. Simms, Zhen Zhao, et al.. (2014). Smoking behaviour modifies IL23r‐associated disease risk in patients with Crohn's disease. Journal of Gastroenterology and Hepatology. 30(2). 299–307. 18 indexed citations
10.
Gathungu, Grace, Mi‐Ok Kim, John Ferguson, et al.. (2013). Granulocyte–Macrophage Colony-Stimulating Factor Autoantibodies. Inflammatory Bowel Diseases. 19(8). 1671–1680. 59 indexed citations
11.
Lawrance, Ian C., Kevin Murray, Richard B. Gearry, et al.. (2013). Crohn's disease and smoking: Is it ever too late to quit?. Journal of Crohn s and Colitis. 7(12). e665–e671. 33 indexed citations
12.
Lawrance, Ian C., Kevin Murray, Richard B. Gearry, et al.. (2013). P365 Smoking and the effect of its cessation on Crohn's disease progression and surgical rates. Journal of Crohn s and Colitis. 7. S155–S156. 1 indexed citations
13.
Croft, Anthony, et al.. (2013). Outcomes of salvage therapy for steroid-refractory acute severe ulcerative colitis: ciclosporin vs. infliximab. Alimentary Pharmacology & Therapeutics. 38(3). 294–302. 69 indexed citations
14.
Martin, Patrick, Anthony Croft, Alissa Walsh, et al.. (2012). Surgical outcomes in steroid refractory acute severe ulcerative colitis: the impact of rescue therapy. Colorectal Disease. 15(3). 374–379. 19 indexed citations
15.
Krishnaprasad, Krupa, Jane M. Andrews, Ian C. Lawrance, et al.. (2011). Inter-observer agreement for Crohn's disease sub-phenotypes using the Montreal Classification: How good are we? A multi-centre Australasian study. Journal of Crohn s and Colitis. 6(3). 287–293. 9 indexed citations
16.
Lawrance, Ian C., Richard B. Gearry, Rachel Grafton, et al.. (2011). Smoking Cessation Following the Diagnosis of Crohn's Disease Still Reduces the Rates of Surgery and Complicated Disease. Gastroenterology. 140(5). S–429. 1 indexed citations
17.
Lawrance, Ian C., Graham Radford‐Smith, Peter A. Bampton, et al.. (2010). Serious infections in patients with inflammatory bowel disease receiving anti‐tumor‐necrosis‐factor‐alpha therapy: An Australian and New Zealand experience. Journal of Gastroenterology and Hepatology. 25(11). 1732–1738. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Timothy E. Ritter Breakdown of academic impact, for papers by Evanthia Zampeli Breakdown of academic impact, for papers by Shashi Adsul Breakdown of academic impact, for papers by Ivan Ferkolj Breakdown of academic impact, for papers by Mireia Peñalva Breakdown of academic impact, for papers by Katrien Asnong Breakdown of academic impact, for papers by Janelle Laskowski Breakdown of academic impact, for papers by B G Feagan Breakdown of academic impact, for papers by Jill Fennell Breakdown of academic impact, for papers by Daniel Quirk
Rankless by CCL
2026